This is the first book of its kind to tie the metabolic syndrome with psychiatric disorders and raise the possibility that common antipsychotic treatments may have this type of adverse effect on patients. Presenting a complete overview and the relationship between insulin resistance syndrome and psychiatric and cognitive disorders, the book will be a welcome addition to the library of any psychiatrist, neurologist, endocrinologist, or research scientist. The book also discusses new treatments to help prevent metabolic complications among patients with neuropsychiatric illnesses, including schizophrenia, Alzheimer’s Disease, and major depression.